- Ventana Medical Systems Inc.
- Alere Inc.
- Beckman Coulter Inc.
- Biosite Inc.
- Becton Dickinson & Co.
- BD Diagnostics-TriPath
- GeneOhm Sciences Inc.
- GE Healthcare
- General Electric Co.
- Abbott Laboratories Inc.
- GE Healthcare Life Sciences
- Siemens AG
- Diagnostic Products Corp.
- Roche Diagnostics Corp.
- Novartis AG
- Plexxikon Inc.
- Roche Molecular Diagnostics
- Affymetrix Inc.
- Roche NimbleGen Inc.
- 454 Life Sciences
- CuraGen Corp.
- BioVeris Corp.
- Roche offers $75 cash/share for histopathology player Ventana
- Inverness Medical buys Biosite
- Beckman Coulter loses bid to acquire Biosite
- BD to buy TriPath for $350mm
- Becton Dickinson acquires GeneOhm Sciences for $230mm in cash
- GE buys Abbott's POC, diagnostics units for $8bn; withdrawn
- GE acquires Amersham PLC for £5.7bn
- Siemens buys Bayer Diagnostics for €4.2bn
- Siemens acquires Diagnostic Products for $1.86bn
- Roche signs on for rights to Plexxikon's PLX4032 cancer agent
- Roche licenses 18-year access to Affymetrix's GeneChip
- Roche joins Affymetrix to develop new PCR GeneChip tests
- Affymetrix and Roche Bioscience in GeneChip deal
- Affymetrix and Roche Molecular develop CF chip
- Roche acquires DNA microarray firm NimbleGen for $272.5mm
- Roche buys sequencing firm 454 Life Sciences for $155mm
- Roche adds immunochemistry tools in $600mm buy of BioVeris
- Roche buys Igen, spins off new company
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.